Searched for
PATIENT SAFETY IN PHARMA
How AI is helping pharma prevent drug recalls, counter fakes and improve patient safetyArtificial intelligence is revolutionizing the pharmaceutical sector by significantly reducing the instances of drug recalls. By improving ...- With a little help from pharma friends: Psychedelics for psychiatric therapyEli Lilly's acquisition signals a return of psychedelic drugs for mental health. These compounds offer a new approach to rewiring neural co...
- Dr Reddy's shares crash 9% in 2 days; brokerages slash target prices after semaglutide supply disruption. What lies ahead?Dr Reddy's Laboratories shares extended their decline after the company delayed commercial supplies of its semaglutide product due to a qua...
- Dr Reddy’s pauses weight loss drug on quality fearsDr Reddy's Laboratories will halt semaglutide injection supplies until at least October. Unspecified impurities were identified during the ...
- Dr Reddy's shares slide 7% after delay in semaglutide supplies over quality concernsDr Reddy's shares fell sharply on Thursday after the company delayed commercial supplies of its semaglutide product due to a quality issue ...
- Why Your Digital Investments Aren’t Creating ValueMany companies are pouring money into AI, analytics, and CRM platforms, yet struggle to translate those investments into measurable revenue...
- Delhi CM Rekha Gupta directs district administration to inspect Shalimar Bagh's Fortis HospitalFortis Hospital inspection: Delhi Chief Minister Rekha Gupta has ordered an immediate inspection of Shalimar Bagh's Fortis Hospital followi...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...
- Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
- Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancerRoche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...
- Drugmakers must report safety data from launch date, not approval date: CDSCOIndia's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be su...
- A full Molnupiravir treatment likely to cost up to Rs 3,000The recommended dose of molnupiravir is 800 mg twice a day for five days. With companies planning to launch 200 mg capsules, a patient will...
- Natco initiates phase-3 clinical trials of Molnupiravir capsules for COVID-19 treatmentNatco Pharma on Friday said it has initiated phase-III clinical trials of Molnupiravir capsules to evaluate its efficacy in treating patien...
- Increased outreach is helping create long term value for India's big pharmaIn recent years, there has been a conscious attempt by companies to increase visibility in the form of increased patient outreach, higher i...
- MNC pharma lobby pushes for single drug authority hereThe OPPI, which represents 22 pharma companies, including Abbott, Pfizer, Novartis, Novo Nordisk and Sanofi, also wants specialised patent ...
- Pharma cos need to quickly learn how to balance interests of investors and patientsLapse in ensuring patient safety is becoming a reason for erosion of shareholder wealth.
- Sun Pharma announces details of psoriasis drug trialsTildrakizumab is a monoclonal antibody designed to control the pathogenic cells responsible for the inflammatory process of psoriasis with ...
- Fallout of new US labelling norms: Lawsuits from across Atlantic loomGeneric drugmakers are not meant to change their product labels until the innovator drug firm updates safety warnings on the label of its c...
- Diabetes drug may cost your heartGovt is contemplating issuing safety alerts on these medicines highlighting the risk of heart failure.
Load More
